HOME >> MEDICINE >> NEWS
NIH halts use of COX-2 inhibitor in large cancer prevention trial

are working closely with our colleagues at FDA to ensure that the public has the information they need to make informed decisions about the use of this class of drug."

"The rigor of our clinical trials system has allowed us to find this problem," said NCI Director Andrew C. von Eschenbach, M.D. "We have a strong system that provides us with the opportunity to both find ways to effectively treat and prevent disease and to do so in a way that protects the lives and safety of the participants."

NIH sponsors over 40 studies using celecoxib for the prevention and treatment of cancer, dementia and other diseases. In light of these new findings, NIH Director Zerhouni requested:

  • a full review of all NIH-supported studies involving this class of drug.
  • NIH Institutes to inform the principal investigators for all of these studies and will ask them to communicate directly with their study participants and explain the risks and benefits
  • NIH to ask each investigator to inform us of the their plan to analyze their data in light of the information
  • the Institutional Review Boards (IRBs) for all related trials to assess the new information and to conduct a safety review as well


'"/>

Contact: John Burklow / Don Ralbovsky
301-496-5787
NIH/Office of the Director
17-Dec-2004


Page: 1 2

Related medicine news :

1. Success of new treatment halts international blood pressure drug trial
2. Researchers identify brain protein that halts progression of Alzheimers
3. New oral medication halts blindness in AIDS patients
4. Enzyme halts muscle waste in mouse models of most-common childhood muscular dystrophy
5. COX-2 inhibitors associated with blood pressure elevation
6. COX-2 product offers good and bad news in test tube strokes
7. COX-2 inhibitor increases the risk of heart attack in elderly adults with no history of heart attack
8. More studies on risks and benefits of COX-2 inhibitors published in Archives of Internal Medicine
9. Special JAMA commentary on lessons learned from troubles with COX-2 inhibitors
10. Estrogen-associated COX-2 pathways explain protection from heart disease in female mice
11. COX-2 inhibitor could be safest anti-inflammatory drug for older people

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/12/2019)... , ... June 12, 2019 , ... ... causing relationships with caregivers and dementia patients to deteriorate. , Researchers from ... included a survey with professional caregivers who care for people who have dementia ...
(Date:6/12/2019)... ... June 12, 2019 , ... NDA Partners ... with more than 25 years of experience in quality systems development, quality systems ... medical devices, has joined NDA Partners as an Expert Consultant. Her experience includes ...
(Date:6/12/2019)... ... ... In September of 2018, NVNA and Hospice (NVNA) partnered with Health Recovery ... its full-scale launch in March, NVNA has expanded its program with HRS to provide ... has achieved an average all-cause hospital readmissions rate of 7.3% and has seen a ...
(Date:6/12/2019)... ... June 12, 2019 , ... We ... fertility care for UPMC Pinnacle, a top-rated healthcare system, providing cutting-edge fertility treatment ... of Excellence for many premier insurance plans because of our commitment to evidence-based ...
(Date:6/12/2019)... ... June 12, 2019 , ... Millions of ... preventing them from participating in education or the workforce, and even from accessing ... recognize communication as a human right and address communication disability in ways that ...
Breaking Medicine News(10 mins):
(Date:6/13/2019)... ... June 13, 2019 , ... Recent lawsuits, ... with a back problem, underscore the responsibility of employers to provide reasonable accommodations ... accommodation requests are reasonable and which are not - from requests by hearing-impaired ...
(Date:6/13/2019)... (PRWEB) , ... June 13, 2019 , ... ... celebrating 10 years of educating medical professionals and the public about non-invasive photobiomodulation ... this fall in Orlando, Florida to help commemorate the milestone. , ...
(Date:6/13/2019)... ... 13, 2019 , ... HMP, a leading healthcare education and events company, today ... 25 Fastest-Growing Shows in Net Square Footage” by Trade Show News Network (TSNN). The ... over that period. Winners will be honored during the 2019 TSNN Awards, taking place ...
Breaking Medicine Technology:
Cached News: